ICU MEDICAL INC/DE (ICUI) Spending and interest coverage
- R&D / revenue · 12 months: Value 4.00%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.55%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 0.87×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 4.00% | Research and development expense / revenue. Period ending 2026-06-30. $86.32M ÷ $2.16B × 100 ≈ 4.00% |
| Stock-based compensation / revenue · 12 months | 2.55% | Share-based compensation / revenue. Period ending 2026-06-30. $55.00M ÷ $2.16B × 100 ≈ 2.55% |
| Interest coverage · 12 months | 0.87× | Operating income ÷ reported interest expense. $72.06M ÷ $83.00M ≈ 0.87× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 86.32M USD | Research and Development Expense |
| Revenue | 2.16B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 55.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 72.06M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 83.00M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $86.32M | $2.16B | $55.00M | $72.06M | $83.00M | 4.00% | 2.55% | 0.87× | Reported |
| 2026-03-31 | $85.48M | $2.16B | $57.59M | $43.52M | $87.80M | 3.96% | 2.67% | 0.50× | Reported |
| 2025-12-31 | $87.50M | $2.23B | $55.76M | $42.83M | $93.34M | 3.92% | 2.50% | 0.46× | Reported |
| 2025-09-30 | $88.76M | $2.32B | $54.40M | $74.89M | $96.63M | 3.83% | 2.34% | 0.77× | Reported |
| 2025-06-30 | $88.54M | $2.37B | $50.92M | $69.40M | $101.51M | 3.73% | 2.15% | 0.68× | Reported |
| 2025-03-31 | $90.06M | $2.42B | $47.46M | $66.51M | $104.80M | 3.72% | 1.96% | 0.63× | Reported |
| 2024-12-31 | $88.61M | $2.38B | $46.88M | $42.96M | $106.54M | 3.72% | 1.97% | 0.40× | Reported |
| 2024-09-30 | $88.67M | $2.34B | $45.05M | $-6.91M | $104.21M | 3.79% | 1.93% | -0.07× | Reported |
| 2024-06-30 | $88.51M | $2.30B | $44.23M | $7.71M | $103.70M | 3.84% | 1.92% | 0.07× | Reported |
| 2024-03-31 | $87.42M | $2.26B | $43.00M | $2.77M | $103.98M | 3.87% | 1.91% | 0.03× | Reported |
| 2023-12-31 | $85.34M | $2.26B | $40.56M | $22.82M | $102.73M | 3.78% | 1.80% | 0.22× | Reported |
| 2023-09-30 | $86.38M | $2.25B | $37.31M | $34.79M | $95.31M | 3.84% | 1.66% | 0.36× | Reported |
| 2023-06-30 | $88.61M | $2.29B | $35.10M | $11.47M | $88.95M | 3.86% | 1.53% | 0.13× | Reported |
| 2023-03-31 | $88.87M | $2.31B | $33.09M | $8.66M | $80.27M | 3.85% | 1.44% | 0.11× | Reported |
| 2022-12-31 | $92.98M | $2.28B | $36.02M | $-42.90M | $70.81M | 4.08% | 1.58% | -0.61× | Reported |
| 2022-09-30 | $82.70M | $2.04B | $36.70M | $-18.85M | $51.43M | 4.05% | 1.80% | -0.37× | Reported |
| 2022-06-30 | $71.84M | $1.78B | $34.49M | $20.00M | $30.45M | 4.03% | 1.94% | 0.66× | Reported |
| 2022-03-31 | $60.66M | $1.54B | $33.41M | $54.51M | $14.34M | 3.94% | 2.17% | 3.80× | Reported |
| 2021-12-31 | $47.50M | $1.32B | $27.34M | $123.25M | $858.00K | 3.61% | 2.08% | 143.64× | Reported |
| 2021-09-30 | $46.13M | $1.30B | $24.58M | $126.44M | $662.00K | 3.56% | 1.90% | 191.00× | Reported |
| 2021-06-30 | $44.02M | $1.28B | $24.31M | $113.59M | $1.11M | 3.44% | 1.90% | 102.33× | Reported |
| 2021-03-31 | $42.91M | $1.26B | $23.04M | $98.67M | $1.72M | 3.40% | 1.83% | 57.44× | Reported |
| 2020-12-31 | $42.95M | $1.27B | $23.95M | $98.16M | $1.75M | 3.38% | 1.88% | 56.00× | Reported |
| 2020-09-30 | $43.74M | $1.27B | $24.37M | $88.97M | $1.72M | 3.45% | 1.92% | 51.69× | Reported |
| 2020-06-30 | $45.61M | $1.25B | $21.83M | $96.33M | $1.24M | 3.63% | 1.74% | 77.44× | Reported |
| 2020-03-31 | $46.53M | $1.26B | $22.65M | $103.05M | $612.00K | 3.68% | 1.79% | 168.37× | Reported |
| 2019-12-31 | $48.61M | $1.27B | $21.92M | $107.36M | $549.00K | 3.84% | 1.73% | 195.56× | Reported |
| 2019-09-30 | $49.55M | $1.29B | $22.41M | $72.26M | $572.00K | 3.84% | 1.74% | 126.33× | Reported |
| 2019-06-30 | $50.73M | $1.31B | $24.92M | $41.62M | $716.00K | 3.87% | 1.90% | 58.12× | Reported |
| 2019-03-31 | $53.10M | $1.36B | $24.99M | $47.07M | $707.00K | 3.91% | 1.84% | 66.58× | Reported |
| 2018-12-31 | $52.87M | $1.40B | $24.24M | $21.61M | $709.00K | 3.78% | 1.73% | 30.48× | Reported |
| 2018-09-30 | $53.22M | $1.43B | $23.96M | $75.29M | $852.00K | 3.72% | 1.68% | 88.37× | Reported |
| 2018-06-30 | $52.81M | $1.45B | $22.31M | $70.77M | $1.27M | 3.65% | 1.54% | 55.55× | Reported |
| 2018-03-31 | $52.20M | $1.42B | $20.81M | $4.84M | $1.67M | 3.68% | 1.47% | 2.90× | Reported |
| 2017-12-31 | $51.25M | $1.29B | $19.35M | $-15.08M | $2.05M | 3.97% | 1.50% | -7.37× | Reported |
| 2017-09-30 | $40.03M | $1.02B | $17.16M | $-42.85M | (m) | 3.93% | 1.69% | (m) | (m) |
| 2017-06-30 | $30.91M | $772.05M | $16.37M | $-16.69M | (m) | 4.00% | 2.12% | (m) | (m) |
| 2017-03-31 | $21.28M | $537.26M | $15.44M | $42.01M | (m) | 3.96% | 2.87% | (m) | (m) |
| 2016-12-31 | $12.96M | $379.37M | $15.24M | $82.94M | (m) | 3.41% | 4.02% | (m) | (m) |
| 2016-09-30 | $14.36M | $374.07M | $14.99M | $81.67M | (m) | 3.84% | 4.01% | (m) | (m) |
| 2016-06-30 | $14.94M | $362.98M | $14.55M | $83.99M | (m) | 4.11% | 4.01% | (m) | (m) |
| 2016-03-31 | $14.72M | $350.04M | $13.82M | $81.54M | (m) | 4.20% | 3.95% | (m) | (m) |
| 2015-12-31 | $15.71M | $341.67M | $12.83M | $68.56M | (m) | 4.60% | 3.75% | (m) | (m) |
| 2015-09-30 | $16.74M | $331.18M | $11.91M | $68.11M | (m) | 5.05% | 3.60% | (m) | (m) |
| 2015-06-30 | $17.57M | $322.62M | $11.08M | $51.76M | (m) | 5.44% | 3.43% | (m) | (m) |
| 2015-03-31 | $19.01M | $317.51M | $10.43M | $40.13M | (m) | 5.99% | 3.29% | (m) | (m) |
| 2014-12-31 | $18.33M | $309.26M | $9.59M | $39.04M | (m) | 5.93% | 3.10% | (m) | (m) |
| 2014-09-30 | $16.71M | $307.31M | $8.29M | $40.54M | (m) | 5.44% | 2.70% | (m) | (m) |
| 2014-06-30 | $14.79M | $312.66M | $7.07M | $47.55M | (m) | 4.73% | 2.26% | (m) | (m) |
| 2014-03-31 | $14.13M | $312.65M | $6.02M | $49.80M | (m) | 4.52% | 1.92% | (m) | (m) |
| 2013-12-31 | $12.41M | $313.72M | $5.43M | $51.95M | (m) | 3.95% | 1.73% | (m) | (m) |
| 2013-09-30 | $11.17M | $318.45M | $5.33M | $57.21M | (m) | 3.51% | 1.68% | (m) | (m) |
| 2013-06-30 | $11.02M | $317.04M | $5.34M | $59.32M | (m) | 3.47% | 1.69% | (m) | (m) |
| 2013-03-31 | $9.84M | $315.66M | $5.72M | $61.92M | (m) | 3.12% | 1.81% | (m) | (m) |
| 2012-12-31 | $10.63M | $316.87M | $5.56M | $61.28M | (m) | 3.35% | 1.76% | (m) | (m) |
| 2012-09-30 | $10.58M | $310.67M | $5.38M | $68.20M | (m) | 3.40% | 1.73% | (m) | (m) |
| 2012-06-30 | $9.47M | $305.72M | $5.08M | $63.96M | (m) | 3.10% | 1.66% | (m) | (m) |
| 2012-03-31 | $9.23M | $306.24M | $4.27M | $64.39M | (m) | 3.01% | 1.39% | (m) | (m) |
| 2011-12-31 | $8.59M | $302.19M | $4.02M | $65.22M | (m) | 2.84% | 1.33% | (m) | (m) |
| 2011-09-30 | $8.16M | $301.35M | $3.90M | $55.98M | (m) | 2.71% | 1.29% | (m) | (m) |
| 2011-06-30 | $7.35M | $300.62M | $3.78M | $57.31M | (m) | 2.45% | 1.26% | (m) | (m) |
| 2011-03-31 | $5.81M | $291.69M | $3.63M | $55.14M | (m) | 1.99% | 1.24% | (m) | (m) |
| 2010-12-31 | $4.68M | $284.58M | $3.47M | $49.28M | (m) | 1.64% | 1.22% | (m) | (m) |
| 2010-09-30 | $3.57M | $278.78M | $3.31M | $43.73M | (m) | 1.28% | 1.19% | (m) | (m) |
| 2010-06-30 | $3.16M | $257.00M | $3.13M | $36.74M | (m) | 1.23% | 1.22% | (m) | (m) |
| 2010-03-31 | $2.83M | $241.54M | $2.93M | $33.61M | (m) | 1.17% | 1.21% | (m) | (m) |
| 2009-12-31 | $2.65M | $231.51M | $2.71M | $37.97M | (m) | 1.14% | 1.17% | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $4.82M | $204.73M | $1.89M | $31.38M | (m) | 2.36% | 0.92% | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $8.11M | $188.14M | $1.05M | $24.65M | (m) | 4.31% | 0.56% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |